000 01557 a2200433 4500
005 20250517021536.0
264 0 _c20160106
008 201601s 0 0 eng d
022 _a1944-8252
024 7 _a10.1021/am5092165
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFang, Chen
245 0 0 _aTemozolomide nanoparticles for targeted glioblastoma therapy.
_h[electronic resource]
260 _bACS applied materials & interfaces
_cApr 2015
300 _a6674-82 p.
_bdigital
500 _aPublication Type: Evaluation Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
650 0 4 _aAnimals
650 0 4 _aAntineoplastic Agents
_xadministration & dosage
650 0 4 _aBrain Neoplasms
_xdrug therapy
650 0 4 _aCell Line, Tumor
650 0 4 _aDacarbazine
_xadministration & dosage
650 0 4 _aDrug Carriers
_xchemistry
650 0 4 _aDrug Delivery Systems
_xinstrumentation
650 0 4 _aGlioblastoma
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aMice
650 0 4 _aMice, Inbred C57BL
650 0 4 _aNanoparticles
_xchemistry
650 0 4 _aTemozolomide
700 1 _aWang, Kui
700 1 _aStephen, Zachary R
700 1 _aMu, Qingxin
700 1 _aKievit, Forrest M
700 1 _aChiu, Daniel T
700 1 _aPress, Oliver W
700 1 _aZhang, Miqin
773 0 _tACS applied materials & interfaces
_gvol. 7
_gno. 12
_gp. 6674-82
856 4 0 _uhttps://doi.org/10.1021/am5092165
_zAvailable from publisher's website
999 _c24688891
_d24688891